EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

FuTURe Study (FUnctional Tricuspid Update Study of REcurrence)—Personalized Risk Stratification for Functional Tricuspid Regurgitation Recurrence After Mitral–Tricuspid Surgery

Maria Grandinetti, Gabriele Mazzenga, Piergiorgio Bruno iD, Giovanni Alfonso Chiariello iD, Annalisa Pasquini, Maria Calabrese, Nicola Testa iD, Marialisa Nesta iD, Monica Filice, Rosa Lillo iD, Federico Cammertoni iD, Natalia Pavone und 2 weitere

Journal of Clinical Medicine · 07.08.2026 · 15 (16) · 6152

DOI: 10.3390/jcm15166152 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 07.08.2026. Verfasst von Maria Grandinetti und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health (Ricerca Corrente 2026).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Functional tricuspid regurgitation (TR) recurrence after concomitant mitral–tricuspid surgery remains associated with adverse long-term outcomes, while reintervention on the isolated tricuspid valve carries substantial operative risk. Despite increasing awareness of the prognostic importance of functional TR, concomitant tricuspid valve repair remains inconsistently adopted in contemporary practice, particularly in technically demanding procedures. We sought to identify predictors of recurrent TR and develop an individualized prediction model to support patient-tailored surgical planning.

Methods

This single-center ambispective study included 178 consecutive patients undergoing concomitant mitral–tricuspid surgery between January 2012 and June 2019. Baseline clinical, echocardiographic and operative variables were retrospectively collected, whereas long-term clinical and echocardiographic follow-up was prospectively completed after Ethics Committee approval. Clinical, echocardiographic and operative variables were first evaluated by univariable Cox proportional hazards analysis. Based on their univariable association with recurrent TR, biological plausibility and clinical relevance, candidate predictors were subsequently entered into a multivariable Cox proportional hazards model while limiting model complexity according to the number of available outcome events. Internal validation was performed by bootstrap resampling, and regression coefficients were transformed into an exploratory individualized perioperative nomogram estimating 5-year tricuspid regurgitation recurrence-free survival.

Results

Univariable analysis identified female sex, dyslipidemia, left ventricular ejection fraction < 45%, severe pre-operative TR, indexed tricuspid annular diameter and suture-based annuloplasty as predictors of recurrent TR. Multivariable analysis identified surgical repair strategy as the only independent predictor associated with recurrent TR, with suture-based annuloplasty showing a significantly higher recurrence risk than prosthetic ring annuloplasty. These variables were integrated into an exploratory individualized prediction model estimating 5-year recurrence-free survival: the FuTURe nomogram.

Conclusions

Our findings confirm the association between prosthetic ring annuloplasty and a lower risk of recurrent TR, consistent with current evidence supporting ring implantation as the preferred repair strategy. Beyond identifying predictors of recurrence, the FuTURe study proposes an exploratory perioperative individualized prediction model intended to complement current guideline recommendations. Consistent with its acronym, the FuTURe study shifts the focus from immediate procedural success to the patient’s future clinical trajectory, highlighting the value of individualized recurrence-risk assessment from a lifetime management perspective.

Schlagwörter

Stichwörter der Autor:innen

functional tricuspid regurgitationpersonalized medicinerisk stratificationtricuspid surgerytricuspid valve

Autor:innen und Institutionen

  • Department of Cardiovascular Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.
  • Faculty of Medicine and Surgery, Catholic University of the Sacred Heart, 00168 Rome, Italy.

ORCID-Profile: Piergiorgio Bruno, Giovanni Alfonso Chiariello, Nicola Testa, Marialisa Nesta, Rosa Lillo, Federico Cammertoni, Francesco Burzotta

Förderung

  • Italian Ministry of Health (Ricerca Corrente 2026)

Zitieren

APA

Grandinetti, M., Mazzenga, G., Bruno, P., Chiariello, G. A., Pasquini, A., Calabrese, M., Testa, N., Nesta, M., Filice, M., Lillo, R., Cammertoni, F., Pavone, N., Burzotta, F., & Massetti, M. (2026). FuTURe Study (FUnctional Tricuspid Update Study of REcurrence)—Personalized Risk Stratification for Functional Tricuspid Regurgitation Recurrence After Mitral–Tricuspid Surgery. Journal of Clinical Medicine, 15(16), 6152. https://doi.org/10.3390/jcm15166152

Vancouver

Grandinetti M, Mazzenga G, Bruno P, Chiariello GA, Pasquini A, Calabrese M, et al. FuTURe Study (FUnctional Tricuspid Update Study of REcurrence)—Personalized Risk Stratification for Functional Tricuspid Regurgitation Recurrence After Mitral–Tricuspid Surgery. Journal of Clinical Medicine. 2026;15(16):6152. doi:10.3390/jcm15166152

BibTeX
@article{Grandinetti2026,
  author = {Grandinetti, Maria and Mazzenga, Gabriele and Bruno, Piergiorgio and Chiariello, Giovanni Alfonso and Pasquini, Annalisa and Calabrese, Maria and Testa, Nicola and Nesta, Marialisa and Filice, Monica and Lillo, Rosa and Cammertoni, Federico and Pavone, Natalia and Burzotta, Francesco and Massetti, Massimo},
  title = {FuTURe Study (FUnctional Tricuspid Update Study of REcurrence)—Personalized Risk Stratification for Functional Tricuspid Regurgitation Recurrence After Mitral–Tricuspid Surgery},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {16},
  pages = {6152},
  doi = {10.3390/jcm15166152}
}
Kostenlos starten →